M

Moderna

Develops mRNA-based medicines for health

Associate Director - Immuno-Oncology Research

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Full-timeCambridge, MA, USA

About the Job

Requirements

  • A PhD in immunology, oncology, or a related biological sciences discipline and at least 7 years of relevant post-PhD experience are required; biotechnology or pharmaceutical experience is preferred.
  • Deep expertise in immuno-oncology and immune cell biology, with substantial experience advancing immune cell-directed therapeutic programs such as T cell engagers, CAR-T therapies, TCR-based therapies, CAR-M therapies, or closely related modalities.
  • Experience managing scientists or research associates in a dynamic environment, setting priorities, executing multiple research workstreams in parallel, and developing talent.
  • Strong written, presentation, and interpersonal communication skills, including the ability to influence, align, and collaborate across multidisciplinary teams and interface with senior leadership.
  • Scientific curiosity and creativity, independence in execution, and adaptability and persistence in pursuing successful outcomes for developing novel immuno-oncology therapeutics.

Responsibilities

  • Provide scientific and people leadership for 1–2 scientist-level research leads responsible for emerging T cell engager and in vivo cell therapy programs, setting priorities, experimental strategies, and decision points across multiple programs.
  • Lead programs from early conceptualization and target assessment through mechanism-of-action studies, lead optimization, candidate selection, and preclinical development readiness.
  • Define and challenge therapeutic hypotheses, target-product concepts, and program strategies by integrating tumor biology, T cell, natural killer cell, and myeloid biology, translational evidence, modality attributes and liabilities, and patient selection considerations.
  • Guide the design and interpretation of in vitro and in vivo studies to characterize potency, selectivity, mechanism of action, resistance mechanisms, durability, and safety-related biology for therapeutic candidates.
  • Partner with the antibody engineering team to optimize therapeutic design, including architecture, binding properties, valency, avidity, activation thresholds, and other attributes that influence efficacy and therapeutic index.
  • Anticipate efficacy and safety risks for immune cell-directed therapeutics and guide experimental strategies to characterize on-target/off-tumor activity, cytokine biology, immune cell dysfunction or exhaustion, and other modality-relevant liabilities.
  • Establish stage-appropriate research plans, success criteria, and data packages that enable programs to progress from discovery into formal preclinical and development activities.
  • Lead cross-functional research teams and program reviews, ensuring that key scientific questions are addressed with fit-for-purpose experiments and that data are translated into clear program decisions and next steps.
  • Identify and evaluate new immuno-oncology targets, combination strategies, and therapeutic concepts to expand the emerging Immuno-Oncology portfolio and address limitations of existing approaches.
  • Collaborate across computational biology, protein engineering, cell engineering, mRNA and delivery sciences, nonclinical safety, translational medicine, CMC, clinical development, and external partners to advance programs efficiently and rigorously.

Desired Qualifications

  • Demonstrated experience designing, leading, and interpreting hypothesis-driven research programs integrating functional assays, mechanistic studies, in vivo pharmacokinetic/pharmacodynamic and efficacy models, and translational data to support therapeutic candidate decisions.
  • Strong understanding of T cell engager, CAR-T, and CAR-M biology, including target selection, immune synapse formation, immune cell activation and cytotoxicity, activation thresholds, exhaustion/dysfunction, trafficking, persistence, resistance mechanisms, and safety considerations relevant to these therapies.
  • Experience assessing therapeutic index and modality-specific liabilities, including target expression and normal-tissue biology, cytokine release, off-tumor activity, immune cell fitness, and other factors influencing efficacy and safety.
  • Experience collaborating across multidisciplinary discovery and development teams, including protein or cell engineering, computational biology, translational research, nonclinical sciences, CMC, clinical biomarker, clinical development, and external partner functions.
  • Demonstrated ability to lead complex, matrixed therapeutic research programs with multiple internal and external dependencies, establish clear scientific priorities, and drive data-based decisions across teams and functions on accelerated timelines.
  • Contributions to high-impact publications, patents, conference presentations, development candidates, or platform technologies in immunology, oncology, cell therapy, or related fields.
  • A desire to make an impact as part of a high-growth, transformational company.

About the Company

Moderna

Develops mRNA-based medicines for health

Moderna develops medicines built on messenger RNA (mRNA). Its products use mRNA delivered into cells to instruct them to produce specific proteins that can prevent or treat disease, with vaccines being a primary example. In practice, a dose delivers engineered mRNA into the body, cells translate it into a target protein, and the immune system responds or the protein modulates biology to combat disease. Moderna differentiates itself through its focus on building a whole mRNA medicines platform and in-house capabilities for designing, manufacturing, and scaling mRNA therapies, including rapid development and large-scale production. Its goal is to create a new category of medicines based on mRNA that can improve how diseases are discovered, developed, and treated, ultimately improving patient outcomes.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2010

Recently Posted Jobs

Explore more opportunities at Moderna

See more jobs